A critical appraisal of the pharmacological management of stable angina

Knuuti, 2020, 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes, Eur Heart J, 41, 407, 10.1093/eurheartj/ehz425 Marzilli, 2012, Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!, J Am Coll Cardiol, 60, 951, 10.1016/j.jacc.2012.02.082 Crea, 2014, Coronary microvascular dysfunction: an update, Eur Heart J, 35, 1101, 10.1093/eurheartj/eht513 Hale, 2008, Late sodium current inhibition as a new cardioprotective approach, J Mol Cell Cardiol, 44, 954, 10.1016/j.yjmcc.2008.03.019 Marketou, 2021, Collaborators from hospital clinics; Collaborators from private practice offices. Clinical characteristics and management of patients with diabetes mellitus and stable coronary artery disease in daily clinical practice. The SCAD-DM Registry, Hellenic J Cardiol, 10.1016/j.hjc.2020.12.006 Nakas, 2019, The importance of characteristics of angina symptoms for the prediction of coronary artery disease in a cohort of stable patients in the modern era, Hellenic J Cardiol, 60, 241, 10.1016/j.hjc.2018.06.003 Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829 Al-Lamee, 2018, ORBITA investigators. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial, Lancet, 391, 31, 10.1016/S0140-6736(17)32714-9 Maron, 2020, Initial Invasive or Conservative Strategy for Stable Coronary Disease, N Engl J Med, 382, 1395, 10.1056/NEJMoa1915922 Tziakas, 2020, ISCHEMIA trial: Is there enough evidence to drive a change in clinical practice? A critical appraisal, Hellenic J Cardiol, 61, 204, 10.1016/j.hjc.2020.08.006 Tsigkas, 2020, Application and clinical implications of revascularization on chronic coronary syndromes: From COURAGE to ISCHEMIA trial, Hellenic J Cardiol, 10.1016/j.hjc.2020.10.004 Weintraub, 2008, Effect of PCI on quality of life in patients with stable coronary disease, N Engl J Med, 359, 677, 10.1056/NEJMoa072771 Farmakis, 2019, Practical Recommendations for the Diagnosis and Medical Management of Stable Angina: An Expert Panel Consensus, J Cardiovasc Pharmacol, 74, 308, 10.1097/FJC.0000000000000716 Koganti, 2020, Association of systemic inflammatory biomarkers with morphological characteristics of coronary atherosclerotic plaque by intravascular optical coherence tomography, Hellenic J Cardiol Aimo, 2020, Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis, Eur J Clin Invest Samuel, 2020, Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Can J Cardiol Ridker, 2017, Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease, N Engl J Med, 377, 1119, 10.1056/NEJMoa1707914 Hartley, 2016, Ranolazine: A Contemporary Review, J Am Heart Assoc, 5 Storey, 2020, Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry), Am J Cardiol, 129, 1, 10.1016/j.amjcard.2020.05.020 Ferrari, 2020, The New ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes: the Good and the Not So Good, Curr Probl Cardiol, 100554